Solara Active Pharma Sciences share news, announcements and annual reports
NSE: SOLARABSE: 541540Pharmaceuticals & BiotechnologySmall Cap
Solara Active Pharma Sciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2018
Last close ₹655.25up ₹1.45 (0.22%)BSE ₹654.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹653.80.
29 Oct: open ₹650.00, high ₹662.30, low ₹646.75
52-week range of traded prices to 29 Oct 2026
₹422.00Low, 30 Mar 2026₹774.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,162 Cr1,182nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 85.59
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 66.80
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,08,382
Solara Active Pharma Sciences has 531 announcements on record, routine notices left out; 12 in the 30 days to 29 Oct 2026, the latest on 17 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Solara Active Pharma Sciences quarterly results
Oct16Fri
The board met on 16 Oct 2026 to consider financial results
Notice filed 9 Oct 2026
Solara Active Pharma Sciences annual reports, presentations and earnings calls
The company's own documents, latest first.Solara Active Pharma Sciences financials, year by year
Annual reports8
- Annual report, year to Mar 202625 Aug 2026
- Annual report, year to Mar 20252 Sep 2025
- Annual report, year to Mar 202426 Sep 2024
- Annual report, year to Mar 20225 Sep 2022, a zip file
- Annual report, year to Mar 202130 Jul 2021, a zip file
3 earlier reports
- Annual report, year to Mar 20207 Jul 2020, a zip file
- Annual report, year to Mar 201919 Jul 2019, a zip file
- Annual report, year to Mar 20184 Oct 2018, a zip file
Investor presentations5
- Updated Investor Presentation2 May 2022
- Investor Presentation11 Apr 2021
- Investor Presentation14 May 2020
- Investor Presentation on Intimation of Analysts / Institutional Investors Conference Call4 May 2020
- Investor Presentation14 Oct 2019
Earnings calls38
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 202623 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 202616 Oct 2026
- Transcript of Earnings conference call pertaining to financial results of the Company for the quarter ended June 30, 202629 Jul 2026
- Audio Recording of the Q1 FY27 Earnings Call held on July 23, 2026 at 16.00 IST23 Jul 2026
- Transcript of earnings conference call pertaining to financial results of the Company for the quarter and year ended March 31, 2026.21 May 2026
33 earlier call documents
- Audio Recording of the Q4 FY26 Earnings Call held on May 15, 2026 at 15.00 IST.15 May 2026
- Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025.10 Feb 2026
- Audio Recording of the Q3 FY26 Earnings Call held on February 06, 2026.6 Feb 2026
- Earnings call Transcript pertaining to the unaudited financials for the quarter and half year ended September 30, 2025.11 Nov 2025
- Audio recording of Q2 FY26 earnings call held on November 05, 2025.5 Nov 2025
- Earnings Call Transcript for the Analysts/Investors Conference Call held on Friday, July 25, 2025.29 Jul 2025
- Link of Recording of the Investors meet held on 25th July 2025 for the quarter ended June 30, 2025.25 Jul 2025
- Earnings Call Transcript of Analysts/Investors Conference Call held on May 15, 202521 May 2025
- Link of Recording15 May 2025
- Earnings Call Transcript for the Board Meeting held on January 24, 202531 Jan 2025
- Audio Link of Recording of the Financial Results for the quarter ended December 31, 202424 Jan 2025
- Earnings Call Transcript for the Board Meeting held on October 21, 2024.28 Oct 2024
- Link of Recording of the Investor's Call in connection with the Unaudited Financial Results for the quarter ended September 30, 202421 Oct 2024
- Transcript26 Jul 2024
- Link of Recording22 Jul 2024
- Transcript4 Jun 2024
- Link of Recording29 May 2024
- Transcript21 Feb 2024
- Link of Recording14 Feb 2024
- Transcript20 Nov 2023
- Link of Recording14 Nov 2023
- Transcript21 Aug 2023
- Link of Recording14 Aug 2023
- Transcript18 May 2023
- Link of Recording12 May 2023
- Transcript1 Feb 2023
- Link of Recording25 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call15 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call9 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call10 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call4 Aug 2022
- Transcript of Earnings Conference call.6 May 2022
- Audio Recording of Analysts/Institutional Investor Meet/Con. Call Held on April 29, 2022.30 Apr 2022
Solara Active Pharma Sciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings8
- For withdrawal of the Composite Scheme of Amalgamation (Merger by Absorption) cum Demerger and Arrangement presented under Sections 230 to 232 read with Section 66 and other applicable provisions of Companies Act, 2013.29 Apr 2022
- Scheme of Arrangement - Approval of revised Scheme of Amalgamation.11 Nov 2021
- Scheme of Arrangement11 Nov 2021
- Amalgamation/Merger - Merger scheme effective - February 1, 202020 Jan 2020
- Amalgamation/Merger - Certified True Copy of NCLT Order dated December 20, 2019.17 Jan 2020
3 earlier filings
- Amalgamation/Merger23 Dec 2019
- Draft Scheme of amalgamation between Solara Active Pharma Sciences Limited and Strides Chemicals Private Ltd.20 Nov 2018
- Board of Directors of the Company at their meeting held on September 28, 2018, has approved the amalgamation of the Company's wholly owned subsidiary Strides Chemicals Private Limited with the Company by way of a scheme of amalgamation, pursuant to Sections 230 to 232 of the Companies Act 2013 and the applicable rules and notifications, thereunder The Proposed Amalgamation is subject to necessary statutory and regulatory approvals including the approvals of the Mumbai Bench of the National Company Law Tribunal along with approvals from the shareholders and creditors of each Strides Chemicals Private Limited and the Company.28 Sep 2018
Solara Active Pharma Sciences share news and announcements
Newest first. Page 1 of 11.
Oct 2026
16 Oct · Business
16 Oct · Business
16 Oct · Disclosure
16 Oct · Disclosure
10 Oct · General Updates
Sep 2026
Aug 2026
25 Aug · General Updates
18 Aug · Disclosure
Jul 2026
23 Jul · Business
23 Jul · Business
23 Jul · Disclosure
Jun 2026
23 Jun · Rating
10 Jun · Legal
The exchange asked on 9 Jun 2026
5 Jun · Updates
May 2026
15 May · Business
15 May · General Updates
15 May · Business
15 May · Disclosure
15 May · General Updates
12 May · Analysts
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 16 Oct 2026Resultsup 7.38%+7.0 pts vs Nifty 500market median −0.7% · five sessions −5.7% (−2.3 pts vs Nifty 500) · volume 20.2× usual · delivery −30.3 pts against usual · The announcement
- 23 Jul 2026Resultsdown 2.31%−1.6 pts vs Nifty 500market median −0.7% · five sessions −5.6% (−6.5 pts vs Nifty 500) · volume 7.3× usual · delivery −30.1 pts against usual · The announcement
- 24 Jun 2026Credit ratingdown 1.17%−1.7 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−2.7 pts vs Nifty 500) · volume 0.7× usual · delivery +4.4 pts against usual · The announcement
- 15 May 2026Resultsup 14.22%+14.6 pts vs Nifty 500market median −0.7% · five sessions +11.1% (+11.2 pts vs Nifty 500) · volume 34.6× usual · delivery −36.2 pts against usual · The announcement
- 6 Feb 2026Resultsdown 10.56%−10.7 pts vs Nifty 500market median −0.7% · five sessions −8.8% (−9.8 pts vs Nifty 500) · volume 7.0× usual · delivery −15.0 pts against usual · The announcement
- 8 Dec 2025Board or managers changeddown 0.31%+1.0 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+7.4 pts vs Nifty 500) · volume 0.6× usual · delivery −10.1 pts against usual · The announcement
- 6 Nov 2025Board or managers changeddown 8.82%−8.1 pts vs Nifty 500market median 0.0% · five sessions −10.3% (−11.0 pts vs Nifty 500) · volume 6.5× usual · delivery +1.3 pts against usual · The announcement
- 6 Nov 2025Resultsdown 8.82%−8.1 pts vs Nifty 500market median −0.7% · five sessions −10.3% (−11.0 pts vs Nifty 500) · volume 6.5× usual · delivery +1.3 pts against usual · The announcement
- 25 Jul 2025Resultsup 6.06%+7.3 pts vs Nifty 500market median −0.7% · five sessions −2.3% (−0.7 pts vs Nifty 500) · volume 6.7× usual · delivery −24.3 pts against usual · The announcement
- 2 Jul 2025Credit ratingdown 0.82%−0.5 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−4.1 pts vs Nifty 500) · volume 0.3× usual · delivery +0.3 pts against usual · The announcement
20 earlier announcements
- 15 May 2025Resultsdown 9.90%−11.2 pts vs Nifty 500market median −0.7% · five sessions −16.8% (−17.9 pts vs Nifty 500) · volume 7.0× usual · delivery −19.6 pts against usual · The announcement
- 24 Feb 2025Board or managers changeddown 3.10%−2.0 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−4.5 pts vs Nifty 500) · volume 3.7× usual · delivery −7.3 pts against usual · The announcement
- 24 Jan 2025Resultsdown 8.41%−7.4 pts vs Nifty 500market median −0.7% · five sessions −26.9% (−25.8 pts vs Nifty 500) · volume 6.7× usual · delivery −33.0 pts against usual · The announcement
- 21 Oct 2024Resultsup 1.51%+2.3 pts vs Nifty 500market median −0.7% · five sessions −8.8% (−4.8 pts vs Nifty 500) · volume 3.6× usual · The announcement
- 22 Jul 2024Resultsup 4.99%+4.6 pts vs Nifty 500market median −0.7% · five sessions +12.6% (+10.7 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 30 May 2024Resultsdown 2.94%−1.9 pts vs Nifty 500market median −0.7% · five sessions −7.9% (−6.9 pts vs Nifty 500) · volume 1.1× usual · delivery −14.0 pts against usual · The announcement
- 15 Feb 2024Board or managers changedup 8.47%+7.9 pts vs Nifty 500market median 0.0% · five sessions +32.3% (+31.3 pts vs Nifty 500) · volume 6.4× usual · delivery −15.9 pts against usual · The announcement
- 7 Aug 2023Board or managers changeddown 0.09%−0.5 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+1.2 pts vs Nifty 500) · volume 1.9× usual · delivery −4.6 pts against usual · The announcement
- 1 Aug 2023Board or managers changedup 0.74%+0.8 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−0.6 pts vs Nifty 500) · volume 0.8× usual · delivery +0.6 pts against usual · The announcement
- 20 Jul 2023Board or managers changedup 0.22%−0.3 pts vs Nifty 500market median 0.0% · five sessions +0.9% (+0.8 pts vs Nifty 500) · volume 0.3× usual · delivery −5.2 pts against usual · The announcement
- 25 Jan 2023Resultsup 4.66%+6.1 pts vs Nifty 500market median −0.7% · five sessions −3.3% (+0.2 pts vs Nifty 500) · volume 14.2× usual · delivery −33.5 pts against usual · The announcement
- 5 Aug 2022Board or managers changeddown 2.90%−2.9 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.8 pts vs Nifty 500) · volume 0.7× usual · delivery +1.6 pts against usual · The announcement
- 4 Aug 2022Resultsdown 0.26%−0.4 pts vs Nifty 500market median −0.7% · five sessions −7.7% (−9.1 pts vs Nifty 500) · volume 3.5× usual · delivery −15.3 pts against usual · The announcement
- 2 May 2022Board or managers changeddown 19.99%−19.7 pts vs Nifty 500market median 0.0% · five sessions −26.4% (−21.0 pts vs Nifty 500) · volume 8.2× usual · delivery −3.1 pts against usual · The announcement
- 9 Mar 2022Board or managers changeddown 0.29%−2.3 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−3.0 pts vs Nifty 500) · volume 0.2× usual · delivery +5.6 pts against usual · The announcement
- 28 Feb 2022Board or managers changedup 0.37%−0.5 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+6.9 pts vs Nifty 500) · volume 0.3× usual · delivery +6.5 pts against usual · The announcement
- 10 Feb 2022Board or managers changeddown 20.00%−20.6 pts vs Nifty 500market median 0.0% · five sessions −31.0% (−29.4 pts vs Nifty 500) · volume 1.2× usual · delivery +55.3 pts against usual · The announcement
- 6 May 2021Dividendup 2.31%+1.6 pts vs Nifty 500market median 0.0% · five sessions +8.3% (+7.3 pts vs Nifty 500) · volume 2.4× usual · delivery −13.6 pts against usual · The announcement
- 11 Nov 2020Dividendup 6.20%+5.4 pts vs Nifty 500market median 0.0% · five sessions +7.9% (+5.4 pts vs Nifty 500) · volume 1.6× usual · delivery −4.3 pts against usual · The announcement
- 30 Oct 2020Board or managers changedup 1.88%+2.0 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−6.6 pts vs Nifty 500) · volume 1.3× usual · delivery −20.2 pts against usual · The announcement
Solara Active Pharma Sciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.